Potential of bone marrow mesenchymal stem cells in management of Alzheimer's disease in female rats

Cell Biology International

Volumn 38, Issue 12, 2014, Pages 1367-1383

  Salem, Ahmed M ^a   Ahmed, Hanaa H ^b   Atta, Hazem M ^c,d   Ghazy, Mohamed A ^a   Aglan, Hadeer A ^b  

^a Ain Shams University   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c Aziz University   (Saudi Arabia)

^d CAIRO UNIVERSITY   (Egypt)

Author keywords

Alzheimer's disease; Bone marrow mesenchymal stem cells; Cerebrolysin; Rats; Rivastigmine

Indexed keywords

CEREBROLYSIN; CHOLINE ACETYLTRANSFERASE; NESTIN; RIVASTIGMINE; SURVIVIN;

ADULT; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BRAIN INJURY; CELL DIFFERENTIATION; CELL HOMING; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HISTOPATHOLOGY; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PROTEIN EXPRESSION; RAT; THERAPY EFFECT; ANIMAL; BIOLOGICAL THERAPY; BONE MARROW CELL; CELL CULTURE; CYTOLOGY; DISEASE MODEL; MESENCHYMAL STROMA CELL; PHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT;

RATTUS;

ALZHEIMER DISEASE; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; HIPPOCAMPUS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS, SPRAGUE-DAWLEY;

EID: 84911421913     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10331     Document Type: Article

References (89)

1. Alhadlaq A, Mao JJ (2004) Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev 13: 436-48.
2. Ali FKh, El-Shafai SA, Samhan FA, Khalil WKB (2008) Effect of water pollution on expression of immune response genes of Solea aegyptiaca in Lake Qarun. African J Biotechnol 7: 1418-25.
3. Alvarez A, Laredo M, Varela M, Cacabelos R, Sanpedro C, Aleixandre M, Linares C, Moessler H (2006) P2-402: doubleblind, placebo-controlled study of three different dosage of cerebrolysin in patients with mild to moderate Alzheimer's disease. Alzheimer's Dementia 2: S364.
4. An J, Beauchemin N, Albanese J, Abney TO, Sullivan AK (1997) Use of a rat cDNA probe specific for the Y chromosome to detect male-derived cells. J Androl 18: 289-93.
5. A.O.A.C. (1995) Official Methods of Analysis. 16th edition. Washington, DC: Association of Official Analysis.
6. Armitage P, Berry G, Matthews JNS (2002) Comparison of several groups. In: Brown A, Pattison F, eds. Statistical Methods in Medical Research, 4th edn. Oxford: Blackwell, pp. 208-234.
7. Bae JS, Jin HK, Lee JK, Richardson JC, Carter JE (2013) Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-b deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer's disease. Curr Alzheimer Res 10(5): 524-31.
8. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer's disease. Lancet 377: 1019-31.
9. Bancroft JD, Gamble M (2008) Theory and practice of histological techniques. 6th edition. Churchill Livingstone-Elsevier, London, pp. 433-69.
10. Banchroft JD, Stevens A, Turner DR (1996) Theory and practice of histological techniques. 4th edition. Philadelphia, PA, USA: Churchill Livingstone, pp. 25-90.
11. Barnes JM, Paget GE (1965) Mechanisms of toxic action. Prog Med Chem 4: 18-38.
12. Battista M, Roberge C, Otis M, Gallo-Payet N (2007) Seladin-1 expression in rat adrenal gland: effect of adrenocorticotropic hormone treatment. J Endocrinol 192: 53-66.
13. Benvenuti S, Saccardi R, Luciani P, Urbani S, Deledda C, Cellai I, Francini F, Squecco R, Rosati F, Danza G, Gelmini S, Greeve I, Rossi M, Maggi R, Serio M, Peri A (2006) Neuronal differentiation of human mesenchymal stem cells: changes in the expression of the Alzheimer's disease-related gene seladin-1. Exp Cell Res 312: 2592-604.
14. Bihaqi SW, Sharma M, Singh AP, Tiwari M (2009) Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain. J Ethnopharmacol 124: 409-15.
15. Bilkei-Gorzó A (1993) Neurotoxic effect of enteral aluminium. Food Chem Toxicol 31: 357-61.
16. Bio-Rad Laboratories, Inc. (2006) Real-time PCR applications guide. Bulletin 5279: 101.
17. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet 368: 387-403.
18. 2+, ATPase activities, antioxidant status and learning performance of aged rats. Neuropsychiatr Dis Treat 4: 687-99.
19. Cenini G, Sultana R, Memo M, Butterfield DA (2008) Elevated levels of proapoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease. J Cell Mol Med 12: 987-94.
20. Chen J, Li Y, Zhang R, Katakowski M, Gautam SC, Xu Y, Lu M, Zhang Z, Chopp M (2004) Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis. Brain Res 1-2: 21-8.
21. Choi MR, Kim HY, Park JY, Lee TY, Baik CS, Chai YG, Jung KH, Park KS, Roh W, Kim KS, Kim SH (2010) Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis. Neurosci Lett 472: 94-8.
22. Cooper-Kuhn CM, Winkler J, Kunhn HG (2004) Decreased neurogenesis after cholinergic forebrain lesion in the adult rat. J Neurosci Res 77: 155-65.
23. Coronel MF, Musolino PL, Villar MJ (2006) Selective migration and engraftment of bone marrow mesenchymal stem cells in rat lumbar dorsal root ganglia after sciatic nerve constriction. Neurosci Lett 405: 5-9.
24. Deveraux QL, Reed JC (1999) IAP family proteins-suppressor of apoptosis. Genes Dev 13: 1253-62.
25. Dharmasaroj P (2009) Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke. J Clin Neurosci 16: 12-20.
26. Dickson TC, Chuckowree JA, Chuah MI, West AK, Vickers JC (2005) Alpha-internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury. Neurobiol Dis 18: 286-95.
27. Dimmeler S, Burchfield J, Zeiher AM (2008) Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 28: 208-16.
28. Gaytan F, Barreiro ML, Caminos JE, Chopin LK, Herington AC, Morales C, Pinilla L, Paniagua R, Nistal FF, Casanueva E, Aguilar E, Dieguez C, Tena-Sempere M (2004) Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors. J Clin Endocrinol Metab 89: 400-9.
29. Gnahn H, Hefti F, Heumann R, Schwab ME, Thoenen H (1983) NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiologic role of NGF in the brain. Dev Brain Res 9: 45-52.
30. Gotz J, Ittner LM (2008) Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 9: 532-44.
31. Greeve I, Hermans-Borgmeyer I, Brellinger C, Kasper D, Gomez-Isla T, Behl C, Levkau B, Nitsch RM (2001) The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J Neurosci 20: 7345-52.
32. Hartbauer M, Hutter-Paier B, Skofitsch G, Windisch M (2001) Antiapoptotic effects of the peptidergic drug cerebrolysin on primary cultures of embryonic chick cortical neurons. J Neural Transm 108(4): 459-73.
33. Huang Y, Peng C, Yang Y, Wu C, Hsu W, Wang H, Chan K, Chou Y, Chen S, Chang Y (2007) Desipramine activated Bcl-2 expression and inhibited lipopolysaccharide-induced apoptosis in hippocampus-derived adult neural stem cells. J Pharmacol Sci 104: 61-72.
34. Jann MW (2000) Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease. Pharmacotherapy 20: 1-12.
35. Ji JF, He BP, Dheen ST, Tay SS (2004) Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22: 415-27.
36. Jiang Y, Saavedra HI, Holloway MP, Leone G, Alture AI (2004) Regulation of survivin by the RB/E2F family of proteins. J Biol Chem 279: 40511-20.
37. Julka D, Sandhir R, Gill KD (1995) Altered cholinergic metabolism in rat CNS following aluminum exposure: implications on learning performance. J Neurochem 5: 2157-64.
38. Karlawish JH, Casarett DJ, James BD, Xie SX, Kim SY (2005) The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment. Neurology 64: 1514-9.
39. Kawahara M, Negishi-Kato M, Sadakane Y (2009) Calcium dyshomeostasis and neurotoxicity of Alzheimer's beta-amyloid protein. Expert Rev Neurother 9: 681-93.
40. Krasovskii GN, Vasukovich LY, Chariev OG (1979) Experimental study of biological effects of leads and aluminum following oral administration. Environ Health Perspect 30: 47-51.
41. Kumar P, Kumar A (2009) Protective effect of rivastigmine against 3 nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations. Eur J Pharmacol 615: 91-101.
42. Kumar BM, Maeng GH, Lee YM, Kim TH, Lee JH, Jeon BG, Ock SA, Yoo JG, Rho GJ (2012) Neurogenic and cardiomyogenic differentiation of mesenchymal stem cells isolated from minipig bone marrow. Res Vet Sci 93(2): 749-57.
43. Lau HY, Bhatia M (2007) Effect of CP-96,345 on the expression of adhesion molecules in acute pancreatitis in mice. Am J Physiol Gastrointest Liver Physiol 292: 1283-92.
44. Lee JK, Jin HK, Bae J (2009) Bone marrow-derived mesenchymal stem cells reduce brain amyloid-b deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model. Neurosci Lett 450: 136-41.
45. Lee JK, Jin HK, Bae JS (2010a) Bone marrow-derived mesenchymal stem cells attenuate amyloid b-induced memory impairment and apoptosis by inhibiting neuronal cell death. Curr Alzheimer Res 7(6): 540-8.
46. Lee JK, Jin HK, Endo S, Schuchman EH, Carter JE, Bae JS (2010b) Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells 28(2): 329-43.
47. Lendahl U, Zimmerman LB, McKay RD (1990) CNS stem cells express a new class of intermediate filament protein. Cell 60: 585-95.
48. Li CQ, Liu D, Wu XQ (2004) Differentiation of rat bone marrow stromal cells into neuron like cells. Zhong NanDa Xue Xue Bao Yi Xue Ban 29: 18-20.
49. Li WY, Jin RL, Hu XY (2012a) Migration of PKH26-labeled mesenchymal stem cells in rats with Alzheimer's disease. Zhejiang Da Xue Xue Bao Yi Xue Ban 41(6): 659-64.
50. Li X, Zhang Z, Yina L, Schluesener HJ (2012b) The profile of bamyloid precursor protein expression of rats induced by aluminum. Environ Toxicol Pharmacol 33: 135-40.
51. Lie DC, Song H, Colamarino SA, Ming GL, Gage FH (2004) Neurogenesis in the adult brain: new strategies for central nervous system diseases. Annu Rev Pharmacol Toxicol 44: 399-421.
52. Liu L, Cao JX, Sun B, Li HL, Xia Y, Wu Z, Tang CL, Hu J (2010) Mesenchymal stem cells inhibition of chronic ethanol-induced oxidative damage via upregulation of phosphatidylinositol-3-kinase/Akt and modulation of extracellular signal-regulated kinase 1/2 activation in PC12 cells and neurons. Neuroscience 167: 1115-24.
53. Ma W, Maric D, Li BS, Hu Q, Andreadis JD, Grant GM, Liu QY, Shaffer KM, Chang YH, Zhang L, Pancrazio JJ, Pant HC, Stenger DA, Barker JL (2000) Acetylcholine stimulates cortical precursor cell proliferation in vitro via muscarinic receptor activation and MAP kinase phosphorylation. Eur J Neurosci 12: 1227-40.
54. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR (2000) Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290: 1779-82.
55. Michalczyk K, Ziman M (2005) Nestin structure and predicted function in cellular cytoskeletal organisation. Histol Histopathol 20: 665-71.
56. Mo S, Zhong Q, Zhou Y, Deng DB, Zhang X (2012) Bone marrowderived mesenchymal stem cells prevent the apoptosis of neuron-like PC12 cells via erythropoietin expression. Neurosci Lett 522: 92-7.
57. Muñoz-Fernández R, Blanco FJ, Frecha C, Martín F, Kimatrai M, Abadía-Molina AC, García-Pacheco JM, Olivares EG (2006) Follicular dendritic cells are related to bone marrow stromal cell progenitors and to myofibroblasts. J Immunol 177: 280-9.
58. Oda Y (1999) Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system. Pathol Int 49: 921-37.
59. Okazaki T, Magaki T, Takeda M, Kajiwara Y, Hanaya R, Sugiyama K, Arita K, Nishimura M, Kato Y, Kurisu K (2008) Intravenous administration of bone marrow stromal cells increases survivin and Bcl-2 protein expression and improves sensorimotor function following ischemia in rats. Neurosci Lett 430: 109-14.
60. Ott HC, McCue J, Taylor DA (2005) Cell-based cardiovascular repair-the hurdles and the opportunities. Basic Res Cardiol 100: 504-17.
61. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ (2004) Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation and differentiation potential. Blood 103: 1662-8.
62. Perry EK, Johnson M, Ekonomou A, Perry RH, Ballard C, Attems J (2012) Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiol Dis 47: 155-62.
63. Phinney DG, Kopen G, Isaacson RL, Prockop DJ (1999) Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth and differentiation. J Cell Biochem 72: 570-85.
64. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult mesenchymal stem cells. Science 284: 143-7.
65. Platt B, Fiddler G, Riedel G, Henderson Z (2001) Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence. Brain Res Bull 55: 257-67.
66. Puppala BL, Matwyshyn G, Bhalla S, Gulati A (2004) Evidence that morphine tolerance may be regulated by endothelin in the neonatal rat. Biol Neonate 86: 138-44.
67. Qin H, Zhao L, Sun J, Ren L, Guo W, Liu H, Zhai S, Yang S (2011) The differentiation of mesenchymal stem cells into inner ear hair cell-like cells in vitro. Acta Oto-Laryngologica 131: 1136-41.
68. Ricchelli F, Drago D, Filippi B, Tognon G, Zatta P (2005) Aluminum-triggered structural modifications and aggregation of b-amyloids. Cell Mol Life Sci 62: 1724-33.
69. Riley C, Hutter-Paier B, Windisch M, Doppler E, Moessler H, Wrowski R (2006) A peptide preparation protects cells in organotypic brain slices against cell death after glutamate intoxication. J Neural Transm 113: 103-10.
70. Rochefort GY, Vaudin P, Bonnet N, Pages JC, Domenech J, Charbord P, Eder V (2005) Influence of hypoxia on the domiciliation of mesenchymal stem cells after infusion into rats: possibilities of targeting pulmonary artery remodeling via cells therapies. Respir Res 6: 125.
71. Rockenstein E, Mante M, Adame A, Crews L, Moessler H, Masliah E (2007) Effects of cerebrolysin on neurogenesis in an APP transgenic model of Alzheimer's disease. Acta Neuropathol 113(3): 265-75.
72. Rombouts WJ, Ploemacher RE (2003) Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 17: 160-70.
73. Sambrook L, Fritsch EF, Manitatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Press.
74. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N, Cooper DR, Sanberg PR (2000) Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164: 247-56.
75. Schäfer S, Calas A, Vergouts M, Hermans E (2012) Immunomodulatory influence of bone marrow-derived mesenchymal stem cells on neuroinflammation in astrocyte cultures. J Neuroimmunol 249: 40-8.
76. Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81: 741-76.
77. Shin JY, Park HJ, Kim HN, Oh SH, Bae JS, Ha HJ, Lee PH (2014) Mesenchymal stem cells enhance autophagy and increase bamyloid clearance in Alzheimer disease models. Autophagy 10(1): 32-44.
78. Si Y, Zhao Y, Hao H, Fu X, Han W (2011) MSCs: biological characteristics, clinical applications and their outstanding concerns. Ageing Res Rev 10: 93-103.
79. Szutowicz A (2001) Aluminum, NO, and nerve growth factor neurotoxicity in cholinergic neurons. J Neurosci Res 66: 1009-18.
80. Tayeb HO, Yang HD, Price BH, Tarazi FI (2012) Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors. Pharmacol Ther 134(1): 8-25.
81. Táyebati SK, Di Tullio MA, Amenta F (2004) Effect of treatment with the cholinesterase inhibitor rivastigmine on vesicular acetylcholine transporter and choline acetyltransferase in rat brain. Clin Exp Hypertens 26: 363-73.
82. Ubhi K, Rockenstein E, Doppler E, Mante M, Adame A, Patrick C, Trejo M, Crews L, Paulino A, Moessler H, Masliah E (2009) Neurofibrillary and neurodegenerative pathology in APPtransgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin. Acta Neuropathol 117(6): 699-712.
83. Van Hoesen GW, Hyman BT, Damasio AR (1991) Entorhinal cortex pathology in Alzheimer's disease. Hippocampus 1: 1-8.
84. Wakabayashi K, Nagai A, Sheikh AM, Shiota Y, Narantuya D, Watanabe T, Masuda J, Kobayashi S, Kim SU, Yamaguchi S (2010) Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J Neurosci Res 88: 1017-25.
85. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC (2004) Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22: 1330-7.
86. Wilkins A, Kemp K, Ginty M, Hares K, Mallam E, Scolding N (2009) Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res 3(1): 63-70.
87. Woolson RF (1987) Statistical methods for the analysis of biomedical data. New York: John Wiley&Sons.
88. Zhang Q, Wang R, Khan M, Mahesh V, Brann DW (2008) Role of Dickkopf-1, an antagonist of the Wnt/b-Catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of Tau phosphorylation. J Neurosci 28(34): 8430-41.
89. Zhao DC, Lei JX, Chen R, Yu WH, Zhang XM, Li SN (2005) Bone marrow-derivedmesenchymal stemcells protect against experimental liver fibrosis in rats. World J Gastroentrol 14: 3431-40.